Evidence map›Paper›PMID 34751293›Full record

ArticleLab on a chip2021

Automated optimization of endoderm differentiation on chip.

Jessi Carolina Ardila Riveros, Anna Karolina Blöchinger, Scott Atwell, Michel Moussus, Nina Compera, Omid Rajabnia, Tihomir Georgiev, Heiko Lickert, Matthias Meier

Open access · hybridAbstract read
In one paragraph

Article in Lab on a chip, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jessi Carolina Ardila RiverosHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.
Anna Karolina BlöchingerInstitute of Diabetes and Regeneration Research, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.
Scott AtwellHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.ORCID 0000-0001-9943-3524
Michel MoussusHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.ORCID 0000-0003-4529-9088
Nina ComperaHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.
Omid RajabniaLaboratory for MEMS Application, IMTEK-Department of Microsystems Engineering, University of Freiburg, Germany.
Tihomir GeorgievHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.
Heiko LickertInstitute of Diabetes and Regeneration Research, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.
Matthias MeierHelmholtz Pioneer Campus, Helmholtz Zentrum München, Munich, Germany. matthias.meier@helmholtz-muenchen.de.ORCID 0000-0001-9455-4538
Helmholtz Zentrum München · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human induced pluripotent stem cells (hiPSCs) can serve as an unlimited source to rebuild organotypic tissues

Indexed as

EndodermInduced Pluripotent Stem CellsCell Culture TechniquesCell DifferentiationHumans

Identifiers

PMID34751293
PMCPMC8613673
OpenAlexW3214179732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.